Gentian Diagnostics ASA
OSL-GENT
NYSE

Healthcare
Medical Devices
Global Rank
#24849
Country Rank
#151
Market Cap
93.32 M
Price
6.05
Change (%)
1.32%
Volume
4,815
Gentian Diagnostics ASA's latest marketcap:
93.32 M
As of 06/07/2025, Gentian Diagnostics ASA's market capitalization has reached $93.32 M. According to our data, Gentian Diagnostics ASA is the 24849th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Market Cap | 93.32 M |
Revenue (ttm) | 15.63 M |
Net Income (ttm) | 4.83 M |
Shares Out | 15.42 M |
EPS (ttm) | 0.3 |
Forward PE | 37.97 |
Ex-Dividend Date | 05/07/2025 |
Earnings Date | 07/10/2025 |
Market Cap Chart
Data Updated: 06/07/2025
Gentian Diagnostics ASA's yearly market capitalization.
Gentian Diagnostics ASA has seen its market value grow from kr839.95 M to kr943.85 M since 2020, representing a total increase of 12.37% and an annual compound growth rate (CAGR) of 2.66%.
Date | Market Cap | Change (%) |
---|---|---|
06/07/2025 | kr943.85 M | 54.08% |
12/30/2024 | kr604.56 M | -5.54% |
12/29/2023 | kr640.03 M | 1.22% |
12/30/2022 | kr632.32 M | -43.06% |
12/30/2021 | kr1.11 B | 32.2% |
12/30/2020 | kr839.95 M |
Company Profile
Gentian Diagnostics ASA was founded in 2001 in Norway.
on the Oslo Børs.
With 63 employees, it focuses on Healthcare and aims to drive innovation in Medical Devices.
Frequently Asked Questions
-
What is Gentian Diagnostics ASA's (OSL-GENT) current market cap?As of 06/07/2025, Gentian Diagnostics ASA (including the parent company, if applicable) has an estimated market capitalization of $93.32 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Gentian Diagnostics ASA (OSL-GENT) rank globally by market cap?Gentian Diagnostics ASA global market capitalization ranking is approximately 24849 as of 06/07/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.